- Editorials The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective
- Carlos Jose Pirola, Silvia Sookoian
- Clin Mol Hepatol. 2024;30(2):174-176.
- Reviews Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
- Silvia Sookoian, Carlos J. Pirola
- Clin Mol Hepatol. 2023;29(Suppl):S184-S195.
- Editorials Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
- Carlos J. Pirola, Silvia Sookoian
- Clin Mol Hepatol. 2022;28(4):806-809.
- Snapshot Personalized medicine in nonalcoholic fatty liver disease
- Carlos J. Pirola, Silvia Sookoian
- Clin Mol Hepatol. 2022;28(4):935-938.
- Reviews Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
- Silvia Sookoian, Carlos J. Pirola
- Clin Mol Hepatol. 2020;26(4):461-475.
- Genetic predisposition in nonalcoholic fatty liver disease
- Silvia Sookoian, Carlos J. Pirola
- Clin Mol Hepatol. 2017;23(1):1-12.